BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 2
• 3
• 4
• 5
• 6
• 9
• 10
• 11
• 12
• 13
• 16
• 17
• 18
• 19
• 20
• 23
• 24
• 25
• 26
• 27
• 30

• Pharm Country

  Xofigo® (radium Ra 223 dichloride) Injection Recommended for Approval in the European Union

  September 20, 2013

   · 

  8 min read
• Creative Biolabs Designs Novel Techniques to Solve Problems Met in Dimerization of ScFv/Fab

  September 20, 2013

   · 

  2 min read
• Business

  Sanovas Raises $6.5 Million Series A1 Round

  September 20, 2013

   · 

  1 min read
• Drug Development

  Janssen Pharmaceuticals, Inc. Confirms XARELTO® is as Effective as the Standard of Care in Treatment of DVT and PE

  September 20, 2013

   · 

  13 min read
• FDA

  Orexo AB Announces the Approval of Abstral® in Japan

  September 20, 2013

   · 

  3 min read
• Pharm Country

  Novartis AG Marks World CML Day With Update on Global Research Program to Evaluate Whether Ph+ CML Patients Can Live Treatment-Free

  September 20, 2013

   · 

  6 min read
• Rafarma Pharmaceuticals (RAFA) Announces Plans for PCAOB-Registrant Audit and Streamlining of Corporate Structure to Upgrade Market Listing

  September 20, 2013

   · 

  2 min read
• Genetown

  Governor Patrick and the Massachusetts Life Sciences Center Celebrate Growth in the Massachusetts Biopharma Industry

  September 20, 2013

   · 

  3 min read
• Otsuka Pharmaceutical Co., Ltd. and Lundbeck Inc. Receive Positive CHMP Opinion in Europe for Abilify Maintena™, a Once-Monthly Injectable for Schizophrenia

  September 20, 2013

   · 

  9 min read
• Deals

  Ergon Capital Said to be Close to $271 Million Sale of ZellBios

  September 20, 2013

   · 

  1 min read